➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
AstraZeneca
Boehringer Ingelheim
McKinsey
Mallinckrodt

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 7,892,733

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,892,733
Title:Response element regions
Abstract: Response element regions, DNA constructs comprising response element regions, host cells comprising response element regions, and methods of using response element regions are provided.
Inventor(s): Saris; Christiaan J. M. (Newbury Park, CA), Summer; Shamin (Oak Park, CA), Mu; Sharon X. (Thousand Oaks, CA), Crouse; Jill A. (Newbury Park, CA)
Assignee: Amgen Inc. (Thousand Oaks, CA)
Application Number:11/112,973
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,892,733
Patent Claims:see list of patent claims

Details for Patent 7,892,733

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen EPOGEN/PROCRIT epoetin alfa VIAL; SINGLE-USE 103234 001 1989-06-01   Start Trial Amgen Inc. (Thousand Oaks, CA) 2024-04-22 RX search
Amgen EPOGEN/PROCRIT epoetin alfa VIAL; MULTIDOSE 103234 002 1989-06-01   Start Trial Amgen Inc. (Thousand Oaks, CA) 2024-04-22 RX search
Amgen EPOGEN/PROCRIT epoetin alfa VIAL; MULTIDOSE 103234 003 1989-06-01   Start Trial Amgen Inc. (Thousand Oaks, CA) 2024-04-22 RX search
Amgen EPOGEN/PROCRIT epoetin alfa VIAL; SINGLE-USE 103234 004 1989-06-01   Start Trial Amgen Inc. (Thousand Oaks, CA) 2024-04-22 RX search
Amgen EPOGEN/PROCRIT epoetin alfa VIAL; SINGLE-USE 103234 005 1989-06-01   Start Trial Amgen Inc. (Thousand Oaks, CA) 2024-04-22 RX search
Amgen EPOGEN/PROCRIT epoetin alfa VIAL; SINGLE-USE 103234 006 1989-06-01   Start Trial Amgen Inc. (Thousand Oaks, CA) 2024-04-22 RX search
Amgen EPOGEN/PROCRIT epoetin alfa VIAL; SINGLE-USE 103234 007 1989-06-01   Start Trial Amgen Inc. (Thousand Oaks, CA) 2024-04-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
McKinsey
Merck
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.